Search

Search Results

• THE DIAGNOSIS OF PSORIATIC ARTHRITIS

  P.S. Helliwell

  61-63

  https://doi.org/10.4081/reumatismo.2007.1s.61

  758

  PDF: 808
• 

  Translation and cross-cultural adaptation into Italian of the self-administered FLARE-RA questionnaire for rheumatoid arthritis

  N. Ughi, T. Schioppo, I. Scotti, V. Merlino, A. Murgo, O. De Lucia, B. Fautrel, F. Guillemin, R. Christensen, F. Ingegnoli

  21-30

  10-04-2020

  https://doi.org/10.4081/reumatismo.2020.1230

  1240

  PDF: 812

• Does magnetic resonance represent the gold-standard of imaging for the follow-up of arthritis?

  M.A. Cimmino

  245-252

  https://doi.org/10.4081/reumatismo.2006.245

  886

  PDF: 2328

• Advances in immunology and rheumatoid arthritis pathogenesis

  G. Valesini, F. Barone, D. Bompanone, M. Catuogno, A. Sili Scavalli

  9-20

  https://doi.org/10.4081/reumatismo.2004.1s.9

  2040

• Rheumatoid arthritis: frequency of hospitalization and evaluation of economic burden

  A. Ciocci, L. Buratti, G. Coari, M. Di Franco, A.M. Iagnocco, M.T. Mauceri, A. Serio

  215-222

  https://doi.org/10.4081/reumatismo.2001.215

  1122

  PDF: 754

• Unexpected and persistent depletion of B lymphocytes CD20 following a minimum dose of anti-CD20 antibody (Rituximab)

  V. Bruzzese, J. Pepe

  306-308

  https://doi.org/10.4081/reumatismo.2009.306

  998

  PDF: 811

• Citrullination: the loss of tolerance and development of autoimmunity in rheumatoid arthritis

  S. Alivernini, A.L. Fedele, I. Cuoghi, B. Tolusso, G. Ferraccioli

  85-94

  https://doi.org/10.4081/reumatismo.2008.85

  1445

  PDF: 1189

• IL-1Ra (recombinant human IL-1 receptor antagonist) in the treatment of rheumatoid arthritis: the efficacy

  U. Fiocco, M. Vezzù, L. Cozzi, S. Todesco

  62-73

  https://doi.org/10.4081/reumatismo.2004.1s.62

  1322

  PDF: 1945

• Case report: rheumatoid arthritis and large granular lymphocytes syndrome

  F. Ingegnoli, M. Arreghini, B. Panni, R. Capra, F. Galbiati, P. Bonara, A. Marchesoni

  357-360

  https://doi.org/10.4081/reumatismo.2002.357

  1121

  PDF: 2152
• 

  Occult axial involvement in patients with psoriatic arthritis mutilans: a case report

  F.M. Perrotta, S. Scriffignano, A. De Socio, E. Lubrano

  88-91

  09-07-2019

  https://doi.org/10.4081/reumatismo.2019.1146

  2002

  PDF: 940

• Switching between TNFα antagonists in rheumatoid arthritis: personal experience and review of the literature

  R. Scrivo, F. Conti, F.R. Spinelli, S. Truglia, L. Magrini, M. Di Franco, F. Ceccarelli, G. Valesini

  107-117

  https://doi.org/10.4081/reumatismo.2009.107

  1939

  PDF: 1183

• Antinuclear, anti-dsDNA and anti-ENA antibodies in patients affected with rheumatoid arthritis or ankylosing spondylitis during treatement with infliximab

  A. Hoxha, A. Ruffatti, P. Grypiotis, M. Podswiadek, C. Botsios, U. Fiocco, L. Punzi, S. Todesco

  121-126

  https://doi.org/10.4081/reumatismo.2006.121

  1780

  PDF: 1733

• Prevalence of rheumatoid arthritis in North Sardinia: the Tempio Pausania’s study

  D. Marotto, M.E. Nieddu, A. Cossu, A. Carcassi

  273-276

  https://doi.org/10.4081/reumatismo.2005.273

  814

  PDF: 2307

• B Lymphocyte stimulator (BLyS) and monocytes: possible role in autoimmune diseases with a particular reference to rheumatoid arthritis

  L. Quartuccio, M. Fabris, G. Ferraccioli

  143-146

  https://doi.org/10.4081/reumatismo.2004.143

  1493

  PDF: 1081

• TNF-α gene polymorphisms in rheumatoid arthritis patients treated with anti-TNF-α agents: preliminary results

  M. Fabris, E. Di Poi, S. Sacco, G. Damante, L. Sinigaglia, G. Ferraccioli

  19-26

  https://doi.org/10.4081/reumatismo.2002.19

  1310

  PDF: 779
• 

  The use of rituximab in idiopathic inflammatory myopathies: description of a monocentric cohort and review of the literature

  S. Barsotti, E. Cioffi, A. Tripoli, A. Tavoni, A. d’Ascanio, M. Mosca, R. Neri

  78-84

  06-07-2018

  https://doi.org/10.4081/reumatismo.2018.1011

  2631

  PDF: 1395

• Safety of rituximab in rheumatoid arthritis

  M. Covelli, P. Sarzi-Puttini, F. Atzeni, P. Macchioni

  101-106

  https://doi.org/10.4081/reumatismo.2010.101

  1705

  PDF: 1034

• Sustained response to infliximab treatment in two cases of early rheumatoid arthritis that has been maintained after drug withdrawal

  P. Caramaschi, S. Pieropan, A. Volpe, A. Carletto, L.M Bambara, D. Biasi

  221-223

  https://doi.org/10.4081/reumatismo.2008.221

  795

  PDF: 1362

• Kidney involvement in rheumatoid arthritis

  A. Icardi, P. Araghi, M. Ciabattoni, U. Romano, P. Lazzarini, G. Bianchi

  76-85

  https://doi.org/10.4081/reumatismo.2003.76

  5612

  PDF: 7665
• 

  Association between red cell distribution width and response to methotrexate in rheumatoid arthritis

  M. Bellan, D. Soddu, E. Zecca, A. Croce, R. Bonometti, R. Pedrazzoli, D. Sola, C. Rigamonti, L.M. Castello, G.C. Avanzi, M. Pirisi, P.P. Sainaghi

  16-20

  10-04-2020

  https://doi.org/10.4081/reumatismo.2020.1243

  1626

  PDF: 790

• Ultrasonographic assessment of the response to Etanercept treatment in patients with rheumatoid arthritis

  A. Iagnocco, C. Perella, F. Ceccarelli, E. Tripodo, C. Alessandri, L. Magrini, G. Valesini

  233-238

  https://doi.org/10.4081/reumatismo.2006.233

  1050

  PDF: 1016

• The psoriatic great toe or the psoriatic onycho-pachydermo-periostitis of great toe (OP3gt)

  R. Ramonda, P. Zucchetta, C. Contessa, L. Punzi

  282-285

  https://doi.org/10.4081/reumatismo.2004.282

  1306

  PDF: 1892
• 

  Treatment patterns of snti-TNF agents in Italy: an observational study

  L. Punzi, M. Matucci Cerinic, F. Cantini, G. Bagnato, U. Fiocco, C. Ferri, S. Bombardieri

  18-28

  https://doi.org/10.4081/reumatismo.2011.18

  1316

  PDF: 988

• Efficacy and safety of anti-TNF agents in the Lombardy rheumatoid arthritis network (LORHEN)

  P. Sarzi- Puttini, M. Antivalle, A. Marchesoni, E.G. Favalli, R. Gorla, M. Filippini, R. Caporali, F. Bobbio-Pallavicini, C. Montecucco, F. Atzeni

  290-295

  https://doi.org/10.4081/reumatismo.2008.290

  2104

  PDF: 1094

• Temporomandibular joint involvement in juvenile idiopathic arthritis: treatment with an orthodontic appliance

  C. Bellintani, P. Ghiringhelli, V. Gerloni, M. Gattinara, G. Farronato, F. Fantini

  201-207

  11-04-2005

  https://doi.org/10.4081/reumatismo.2005.201

  1528

  PDF: 1852

• Anti-chromatin antibodies in juvenile rheumatoid arthritis

  F. Ingegnoli, N. Del Papa, E. Lupi, D.P. Comina, W. Maglione, V. Gerloni, F. Fantini

  240-244

  https://doi.org/10.4081/reumatismo.2003.240

  1238

  PDF: 992

• Stress response system and personality in rheumatoid arthritis patients

  C. Prete, F. Briano, C. Pizzorni, A. Sulli, M. Marcenaro, M. Cutolo

  204-209

  https://doi.org/10.4081/reumatismo.2001.204

  1395

  PDF: 904
• 

  Jaccoud’s arthropathy, an unusual manifestation of idiopathic retroperitoneal fibrosis: rapid improvement of symptoms after tocilizumab treatment

  M. Benucci, A. Damiani, F. Li Gobbi, V. Grossi, M. Infantino, A. Arena, M. Manfredi

  88-91

  03-08-2017

  https://doi.org/10.4081/reumatismo.2017.968

  2104

  PDF: 1016

• Neprhrotic syndrome in a patient with rheumatoid arthritis treated with adalimumab: a case report

  M.G. Portuesi, P. Perosa

  61-63

  https://doi.org/10.4081/reumatismo.2008.61

  1195

  PDF: 899

• Therapeutic gene transfer for rheumatoid arthritis

  M.C. Boissier, N. Bessis

  51-61

  https://doi.org/10.4081/reumatismo.2004.1s.51

  731

  PDF: 722

• Anti-tissue transglutaminase antibodies in inflammatory and degenerative arthropathies

  A. Spadaro, M.L. Sorgi, R. Scrivo, A. Picarelli, M. Di Tola, L. Sabbatella, E. Taccari

  344-350

  https://doi.org/10.4081/reumatismo.2002.344

  1116

  PDF: 1678

• Severe drug hypersensitivity syndrome due to sulphasalazine in patient with rheumatoid arthritis

  M. Gutierrez, E. Filippucci, L. Bugatti, C. Bertolazzi, W. Grassi

  65-68

  https://doi.org/10.4081/reumatismo.2009.65

  1381

  PDF: 1081

• Anti-TNFa treatment in patients with rheumatoid arthritis and anti-Ro/SSA antibodies

  I. Cavazzana, F. Franceschini, E. Danieli, M. Frassi, M. Vianelli, R. Gorla, P. Airò, R. Cattaneo

  267-272

  https://doi.org/10.4081/reumatismo.2005.267

  1086

  PDF: 1739
• 

  Axial and peripheral spondyloarthritis triggered by sars-cov-2 infection: a report of two cases

  G. El Hasbani, A. Jawad, I. Uthman

  59-63

  19-04-2021

  https://doi.org/10.4081/reumatismo.2021.1374

  5352

  PDF: 1480

• Knee radiosynovectomy with Y90 in patients with rheumatoid arthritis: our experiences

  W. Troise Rioda, A. Nervetti, G. Ugolotti, G. Adorni

  206-211

  https://doi.org/10.4081/reumatismo.2008.206

  1098

  PDF: 1845

• Synoviocyte cultures from synovial fluid

  A. Scanu, F. Oliviero, L. Braghetto, R. Ramonda, R. Luisetto, F. Calabrese, A. Pozzuoli, L. Punzi

  66-70

  https://doi.org/10.4081/reumatismo.2007.66

  1672

  PDF: 1083

• Rheumatoid factor positivity rather than anti-CCP positivity, a lower disability and a lower number of anti-TNFα agents failed are associated with response to rituximab in rheumatoid arthritis

  L. Quartuccio, S. Salvin, M. Saracco, S. Lombardi, M. Fabris, E. Mansutti, M. Maset, S. Pellerito, S. De Vita

  182-186

  https://doi.org/10.4081/reumatismo.2009.182

  1035

  PDF: 744

• Atherosclerosis and rheumatoid arthritis: relationships between intima-media thickness of the common carotid arteries and disease activity and disabilty

  G. Cuomo, P. Di Micco, A. Niglio, G. La Montagna, G. Valentini

  242-246

  https://doi.org/10.4081/reumatismo.2004.242

  1534

  PDF: 1301

• short history of anti-rheumatic therapy. IV. Corticosteroids

  G. Pasero, P. Marson

  292-299

  https://doi.org/10.4081/reumatismo.2010.292

  1819

  PDF: 1989

• Tenosynovitis of the ankles as onset of sarcoidosis in a patient with ulcerative colitis

  A. Furlan, M. Podswiadek, F. Cozzi, S. Todesco

  197-200

  11-04-2005

  https://doi.org/10.4081/reumatismo.2005.197

  1437

  PDF: 1446
• 

  Hand dominance in early and established rheumatoid arthritis: evaluation by dynamometer, Ritchie index and musculoskeletal ultrasound: a cross sectional study

  A.M. Elsaman, A. Sayed, A.R. Radwan

  131-144

  19-11-2020

  https://doi.org/10.4081/reumatismo.2020.1273

  1435

  PDF: 812

• Cardiac involvement in rheumatoid arthritis

  M. Turiel, S. Sitia, L. Tomasoni, S. Cicala, F. Atzeni, L. Gianturco, M. Longhi, V. De Gennaro Colonna, P. Sarzi-Puttini

  244-253

  https://doi.org/10.4081/reumatismo.2009.244

  1976

  PDF: 1376

• Reconstructing the pyramid as a therapeutic approach to rheumatoid arthritis

  G. Ferraccioli

  46-50

  https://doi.org/10.4081/reumatismo.2004.1s.46

  718

  PDF: 707

• Analysis of foot structural damage in rheumatoid arthritis: clinical evaluation by validated measures and serological correlations

  D. Biscontini, E. Bartoloni Bocci, R. Gerli

  48-53

  https://doi.org/10.4081/reumatismo.2009.48

  1450

  PDF: 1017

• Diff-Quik® staining method for detection and identification of monosodium urate and calcium pyrophosphate crystals in synovial fluids

  S. Manganelli, E. Selvi, M. Catenaccio, S. Cucini, R. De Stefano, E. Frati, M. Hammoud, R. Marcolongo

  305-308

  https://doi.org/10.4081/reumatismo.2001.305

  1428

  PDF: 887
• 

  Assessment of patients affected by rheumatoid arthritis eligible for biotechnological agents and evaluation of their healthcare resource utilization and related costs

  L. Degli Esposti, V. Perrone, D. Sangiorgi, L. Sinigaglia

  5-14

  19-04-2021

  https://doi.org/10.4081/reumatismo.2021.1329

  3854

  PDF: 576

• Long-term evaluation of infliximab in the treatment of persistently active juvenile idiopathic arthritis refractory to conventional therapy

  G. De Marco, V. Gerloni, I. Pontikaki, A. Lurati, B. Teruzzi, A. Salmaso, E. Valcamonica, M. Gattinara, F. Fantini

  50-56

  https://doi.org/10.4081/reumatismo.2007.50

  1179

  PDF: 811

• Subclinical atherosclerosis in young patients with rheumatoid arthritis and low disease activity

  E. Bartoloni Bocci, S. Marchesi, F. Delle Monache, G. Vaudo, A. Giordano, F. Ragni Alunni, C. Angrisani, E. Mannarino, Y. Shoenfeld, R. Gerli

  16-21

  https://doi.org/10.4081/reumatismo.2005.16

  993

  PDF: 947

• Hidden bone erosions

  E. Filippucci, A. Farina, F. Salaffi, W. Grassi

  52-55

  https://doi.org/10.4081/reumatismo.2003.52

  1112

  PDF: 4799
• 

  Anti-tumor necrosis factor α: originators versus biosimilars, comparison in clinical response assessment in a multicenter cohort of patients with inflammatory arthropathies

  C. Gioia, A. Picchianti Diamanti, R. Perricone, M.S. Chimenti, A. Afeltra, L. Navarini, A. Migliore, U. Massafra, V. Bruzzese, P. Scolieri, C. Meschini, M. Paroli, R. Caccavale, P. Scapato, R. Scrivo, F. Conti, B. Laganà, M. Di Franco

  19-12-2023

  https://doi.org/10.4081/reumatismo.2023.1602

  1913

  PDF: 469